Back to 
BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP
ALXNShowing 0 of 10 quarters
Position history for BAKER BROS. ADVISORS LP's holdings in ALEXION PHARMACEUTICALS INC
No. Baker Bros. Advisors exited its ALXN (Alexion Pharmaceuticals) position in Q2 2021. Its Q1 2021 13F listed 3,993,312 shares worth $610.6M. Baker Bros. Advisors already held ALXN in its Q1 2019 13F, the earliest on record, and held it in 9 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ALXN: FMR LLC, STATE STREET CORP